Log in to save to my catalogue

Prognostic impact of bridge or neoadjuvant induction chemotherapy in patients with resected oral cav...

Prognostic impact of bridge or neoadjuvant induction chemotherapy in patients with resected oral cav...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_32decb1df61e4860b32b06ea94b82311

Prognostic impact of bridge or neoadjuvant induction chemotherapy in patients with resected oral cavity cancer: A nationwide cohort study

About this item

Full title

Prognostic impact of bridge or neoadjuvant induction chemotherapy in patients with resected oral cavity cancer: A nationwide cohort study

Publisher

United States: John Wiley & Sons, Inc

Journal title

Cancer Medicine, 2024-08, Vol.13 (15), p.e70061-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
While surgery remains the primary treatment for oral squamous cell carcinoma (OCSCC), induction chemotherapy (IC) can be used as a bridging or neoadjuvant therapy. This nationwide study in Taiwan examines the survival outcomes of OCSCC patients who received IC before surgery.
Methods
We analyzed data from 29,891 patients with OC...

Alternative Titles

Full title

Prognostic impact of bridge or neoadjuvant induction chemotherapy in patients with resected oral cavity cancer: A nationwide cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_32decb1df61e4860b32b06ea94b82311

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_32decb1df61e4860b32b06ea94b82311

Other Identifiers

ISSN

2045-7634

E-ISSN

2045-7634

DOI

10.1002/cam4.70061

How to access this item